UnitedHealth Looks Beyond These Borders

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

When President Obama was re-elected, shares of UnitedHealth Group (NYSE:UNH) and other life insurers fell immediately. Is Obamacare a death knell for health insurers, or is the market missing out on some of the opportunities the law presents? Of course, one way to offset any negative impact from the law is to grow in areas where it doesn't apply. In our brand-new premium report on UnitedHealth, which homes in on UnitedHealth's prospects in a post-Obamacare world, we highlight one way the company is looking to grow beyond borders. Read on for a free sample.

Beyond Borders
In October 2012, UnitedHealth announced the acquisition of Brazil's largest health-care organization, Amil Participacoes S.A. This move opens up a significant new opportunity for growth beyond U.S. borders.

Brazil represents the largest market for private health care in the Western Hemisphere outside of the U.S. The market penetration for managed care in the country currently stands near 25%, much lower than the 80% penetration in the U.S. Better yet, per-capita GDP in Brazil has grown at an average rate in excess of 19% for nearly 10 years, making health care more affordable for an increasing percentage of the population.

Amil brings several assets to UnitedHealth. The company owns hospitals and clinics, along with several outpatient facilities and emergency care centers. Amil also boasts the largest care network in Brazil with 44,000 doctors, 12,000 ancillary service facilities, almost 11,000 outpatient clinics, and 3,300 hospitals.

UnitedHealth estimates annual revenue for Amil around $5 billion this year. While that amounts to only a small fraction of the company's U.S. revenue, Amil's year-on-year growth in the double-digits, combined with a large untapped Brazilian market bode well for UnitedHealth's prospects below the equator.

Keep reading
We hope you enjoyed this short excerpt from our premium report on UnitedHealth. In the full version, we run through the key opportunities and threats facing the company, provide reasons to both buy and sell the stock, and include a full year of analyst updates to keep you covered as key news develops. Don't miss out -- simply click here now to claim your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2166587, ~/Articles/ArticleHandler.aspx, 10/22/2016 4:50:56 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:01 PM
UNH $145.37 Up +0.30 +0.21%
UnitedHealth Group CAPS Rating: ****